Dynamics of in vitro polymer degradation\ud of polycaprolactone-based scaffolds :\ud accelerated versus simulated physiological\ud conditions

The increasing use of biodegradable devices in tissue engineering and regenerative medicine\ud means it is essential to study and understand their degradation behaviour. Accelerated\ud degradation systems aim to achieve similar degradation profiles within a shorter period of\ud time, compared with standard conditions. However, these conditions only partially mimic the\ud actual situation, and subsequent analyses and derived mechanisms must be treated with\ud caution and should always be supported by actual long-term degradation data obtained under\ud physiological conditions. Our studies revealed that polycaprolactone (PCL) and\ud PCL-composite scaffolds degrade very differently under these different degradation\ud conditions, whilst still undergoing hydrolysis. Molecular weight and mass loss results differ\ud due to the different degradation pathways followed (surface degradation pathway for\ud accelerated conditions and bulk degradation pathway for simulated physiological conditions).\ud Crystallinity studies revealed similar patterns of recrystallization dynamics, and mechanical\ud data indicated that the scaffolds retained their functional stability, in both instances, over the\ud course of degradation. Ultimately, polymer degradation was shown to be chiefly governed by\ud molecular weight, crystallinity susceptibility to hydrolysis and device architecture\ud considerations whilst maintaining its thermodynamic equilibrium